Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway
N
Shared by NobleBlocks on Aug 1, 2015 • 12:00 AM UTC
Authors:
Michael Lahn
,
Stephan Herbertz
,
J. Scott Sawyer
Research Assistant
AI chat, annotations, notes & similar papers
Finding related papers...
Discussions
(0)
No comments yet
Be the first to share your thoughts!
Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway | NobleBlocks
